| abstract |
The present invention generally relates to methods of using dopachrome tautomerase activity of macrophage migration inhibitory factor (MIF) and related or other proteins present in the seminal fluid (ejaculate) of a male subject to evaluate fertility and other related diseases. Further utilities relate to the diagnosis and treatment of fertility, to new methods of contraception, and to methods of enhancing artificial insemination and in vitro fertilization. |